Takeda Pharmaceutical Co Ltd Stock Ownership - Who owns Takeda Pharmaceutical Co?

Insider buying vs selling

Have Takeda Pharmaceutical Co Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TAK insiders and whales buy or sell their stock.

TAK Shareholders

What type of owners hold Takeda Pharmaceutical Co Ltd stock?
Mondrian Investment Partners Ltd0.29%4,751,715$75.88MInstitution
Morgan Stanley0.28%4,623,007$73.83MInstitution
Clal Insurance Enterprises Holdings Ltd0.26%4,340,500$69.32MInstitution
Goldman Sachs Group Inc0.26%4,272,469$68.23MInstitution
Macquarie Group Ltd0.24%3,994,044$63.78MInstitution
Renaissance Technologies LLC0.17%2,849,100$45.50MInstitution
Blackrock Inc0.13%2,230,997$35.63MInstitution
Northern Trust Corp0.13%2,192,587$35.02MInstitution
Fmr LLC0.12%2,009,910$32.10MInstitution
Brandes Investment Partners LP0.11%1,871,043$29.88MInstitution

1 of 3

TAK vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZTS90.26%5.50%Net Selling
VTRS74.75%17.41%Net SellingNet Selling
TEVA50.39%0.75%Net Selling
CTLT78.21%21.79%Net SellingNet Selling

Takeda Pharmaceutical Co Stock Ownership FAQ

Who owns Takeda Pharmaceutical Co?

Takeda Pharmaceutical Co (NYSE: TAK) is owned by 3.82% institutional shareholders, 0.00% Takeda Pharmaceutical Co insiders, and 96.18% retail investors. Mondrian Investment Partners Ltd is the largest individual Takeda Pharmaceutical Co shareholder, owning 4.75M shares representing 0.29% of the company. Mondrian Investment Partners Ltd's Takeda Pharmaceutical Co shares are currently valued at $75.88M.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.